Aptose Biosciences (APTO) Short Interest Ratio & Short Volume → Elon Musk’s Final Masterpiece: “X-9840” (From Paradigm Press) (Ad) Free APTO Stock Alerts $1.16 +0.02 (+1.75%) (As of 05/30/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Aptose Biosciences Short Interest DataCurrent Short Interest68,100 sharesPrevious Short Interest83,500 sharesChange Vs. Previous Month-18.44%Dollar Volume Sold Short$82,401.00Short Interest Ratio1.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares16,290,000 sharesFloat Size9,700,000 sharesShort Percent of Float0.70%Today's Trading Volume64,088 sharesAverage Trading Volume50,114 sharesToday's Volume Vs. Average128% Short Selling Aptose Biosciences ? Sign up to receive the latest short interest report for Aptose Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPTO Short Interest Over TimeAPTO Days to Cover Over TimeAPTO Percentage of Float Shorted Over Time Ad Wealthpin ProDo This Before July 30 2024 To Claim Trump’s Gift In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. Aptose Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202468,100 shares $82,401.00 -18.4%0.7%1 $1.21 4/30/202483,500 shares $100,200.00 +52.1%0.9%1.1 $1.20 4/15/202454,900 shares $71,370.00 -35.9%0.6%0.6 $1.30 3/31/202485,600 shares $142,096.00 +70.5%0.9%0.9 $1.66 3/15/202450,200 shares $76,304.00 -28.7%0.5%0.5 $1.52 2/29/202470,400 shares $126,720.00 -22.3%0.8%0.8 $1.80 Get the Latest News and Ratings for APTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/202490,600 shares $183,265.68 -53.0%1.0%1 $2.02 1/31/2024192,600 shares $385,200.00 +31.9%6.2%2.5 $2.00 1/15/2024146,000 shares $332,880.00 +66.5%4.0%2.6 $2.28 12/31/202387,700 shares $222,758.00 +32.3%2.4%1.6 $2.54 12/15/202366,300 shares $157,131.00 +193.4%1.8%1.3 $2.37 11/30/202322,600 shares $54,918.00 -25.9%0.7%0.5 $2.43 11/15/202330,500 shares $82,655.00 -27.2%1.0%0.8 $2.71 10/31/202341,900 shares $116,901.00 +37.8%1.7%1 $2.79 10/15/202330,400 shares $65,056.00 -24.4%1.2%0.7 $2.14 9/30/202340,200 shares $112,560.00 +37.7%1.8%1 $2.80 9/15/202329,200 shares $96,068.00 -22.8%1.3%0.7 $3.29 8/31/202337,800 shares $153,090.00 -7.1%1.8%0.8 $4.05 8/15/202340,700 shares $199,430.00 -12.9%1.3%0.9 $4.90 7/31/202346,700 shares $144,770.00 -28.4%2.2%1.1 $3.10 7/15/202365,200 shares $288,836.00 -18.2%3.1%1.8 $4.43 6/30/202379,700 shares $369,808.00 -3.4%1.4%2.5 $4.64 6/15/202382,500 shares $485,925.00 +167.0%1.4%2.9 $5.89 5/31/202330,900 shares $190,035.00 -88.3%N/A1.6 $6.15 5/15/2023264,100 shares $124,655.20 +44.6%0.3%1.5 $0.47 4/30/2023182,700 shares $88,189.29 +11.3%0.2%1.1 $0.48 4/15/2023164,100 shares $84,027.41 -37.4%0.2%0.9 $0.51 3/31/2023262,200 shares $167,808.00 +53.3%0.3%1.4 $0.64 3/15/2023171,000 shares $99,180.00 -3.0%0.2%0.8 $0.58 2/28/2023176,200 shares $102,548.40 +0.7%0.2%0.6 $0.58 2/15/2023175,000 shares $119,000.00 -13.9%0.2%0.6 $0.68 1/31/2023203,300 shares $152,475.00 -74.0%0.2%0.7 $0.75 1/15/2023782,400 shares $547,680.00 -19.6%0.9%1.8 $0.70 12/30/2022973,500 shares $564,630.00 -3.6%N/A2.3 $0.58 12/15/20221,010,000 shares $591,153.00 +29.1%N/A2.5 $0.59 11/30/2022782,300 shares $520,229.50 +13.0%N/A2.2 $0.67 11/15/2022692,100 shares $472,289.04 +163.7%N/A1.9 $0.68 10/31/2022262,500 shares $120,881.25 -4.0%N/A0.7 $0.46 10/15/2022273,300 shares $155,808.33 +14.6%N/A1.3 $0.57 9/30/2022238,400 shares $141,848.00 -2.9%N/A1.3 $0.60Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 9/15/2022245,600 shares $170,937.60 +18.7%N/A1.3 $0.70 8/31/2022206,900 shares $161,795.80 -15.9%N/A1 $0.78 8/15/2022245,900 shares $213,933.00 -16.7%N/A1.1 $0.87 7/31/2022295,100 shares $218,993.71 +10.5%N/A1.1 $0.74 7/15/2022267,100 shares $223,055.21 +4.8%N/A0.9 $0.84 6/30/2022255,000 shares $189,235.50 -38.2%N/A0.7 $0.74 6/15/2022412,300 shares $349,671.63 -16.3%N/A1 $0.85 5/31/2022492,500 shares $497,425.00 +0.4%0.6%1.2 $1.01 5/15/2022490,800 shares $510,432.00 +5.0%0.6%1.2 $1.04 4/30/2022467,500 shares $556,325.00 +5.9%0.6%1.1 $1.19 4/15/2022441,500 shares $551,875.00 +3.8%0.5%1.1 $1.25 3/31/2022425,400 shares $578,544.00 -4.8%0.5%1 $1.36 3/15/2022446,600 shares $473,396.00 -21.7%0.6%0.9 $1.06 2/28/2022570,400 shares $684,480.00 +2.8%0.7%0.6 $1.20 2/15/2022554,900 shares $682,527.00 -5.7%0.7%0.6 $1.23 1/31/2022588,200 shares $764,660.00 -3.8%0.7%0.5 $1.30 1/15/2022611,700 shares $819,678.00 -4.2%0.8%0.5 $1.34 12/31/2021638,400 shares $861,840.00 -11.7%0.8%0.5 $1.35 12/15/2021722,700 shares $860,013.00 -2.9%0.9%0.6 $1.19 11/30/2021744,300 shares $1.64 million -16.3%0.9%0.9 $2.20 11/15/2021889,100 shares $2.29 million -5.2%1.1%1 $2.58 10/29/2021937,600 shares $1.92 million +2.4%1.2%1 $2.05 10/15/2021916,100 shares $2.11 million +16.6%1.2%1 $2.30 9/30/2021785,600 shares $1.71 million -16.7%1.0%0.8 $2.18 9/15/2021942,600 shares $2.55 million -7.6%1.2%0.9 $2.71 8/31/20211,020,000 shares $3.05 million -12.8%1.3%0.7 $2.99 8/13/20211,170,000 shares $3.08 million -7.9%1.5%0.9 $2.63 7/30/20211,270,000 shares $3.42 million -24.4%1.7%1 $2.69 7/15/20211,680,000 shares $4.80 million -42.3%2.0%1.4 $2.86 6/30/20212,910,000 shares $9.66 million -4.0%3.5%2.4 $3.32 6/15/20213,030,000 shares $10.61 million -1.3%3.7%0.7 $3.50 5/28/20213,070,000 shares $16.27 million -1.3%3.7%0.8 $5.30 5/14/20213,110,000 shares $14.37 million -7.4%3.8%0.8 $4.62 4/30/20213,360,000 shares $18.92 million -8.9%4.1%0.8 $5.63 4/15/20213,690,000 shares $19.22 million -23.1%4.5%0.9 $5.21 3/31/20214,800,000 shares $29.86 million +98.4%5.9%1.1 $6.22 3/15/20212,420,000 shares $9.56 million +8.0%3.0%0.6 $3.95 2/26/20212,240,000 shares $8.92 million +1.8%2.7%1.5 $3.98 2/12/20212,200,000 shares $10.23 million -26.7%2.7%1.5 $4.65 1/29/20213,000,000 shares $12.75 million -11.8%3.6%1.9 $4.25 1/15/20213,400,000 shares $14.93 million -24.8%4.0%2.1 $4.39 12/31/20204,520,000 shares $19.26 million -3.8%5.4%2.8 $4.26 12/15/20204,700,000 shares $18.99 million +49.2%5.6%3.1 $4.04 11/30/20203,150,000 shares $19.78 million +38.2%3.8%2.3 $6.28 11/15/20202,280,000 shares $12.22 million +7.6%2.7%2.3 $5.36 10/30/20202,120,000 shares $9.75 million +12.8%2.6%2.5 $4.60 10/15/20201,880,000 shares $11.05 million -25.7%2.3%2.1 $5.88 9/30/20202,530,000 shares $15.18 million +5.0%3.1%2.6 $6.00 9/15/20202,410,000 shares $14.24 million +24.9%2.9%2.5 $5.91 8/31/20201,930,000 shares $10.81 million -5.9%2.3%2 $5.60Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 8/14/20202,050,000 shares $10.50 million -5.5%2.5%2.5 $5.12 7/31/20202,170,000 shares $10.98 million +22.6%2.7%2.5 $5.06 7/15/20201,770,000 shares $10.05 million +9.9%2.2%2 $5.68 6/30/20201,610,000 shares $10.16 million -13.4%2.3%2.1 $6.31 6/15/20201,860,000 shares $12.74 million +2.2%2.6%2.4 $6.85 5/29/20201,820,000 shares $13.43 million -8.1%2.6%2.1 $7.38 5/15/20201,980,000 shares $15.58 million +99.7%2.8%2.1 $7.87 4/30/2020991,600 shares $6.85 million +59.6%1.4%1 $6.91 4/15/2020621,300 shares $4.86 million +29.6%0.9%0.6 $7.83 3/31/2020479,500 shares $3.94 million +30.5%0.7%0.5 $8.22 3/13/2020367,400 shares $2.31 million -5.8%0.5%0.4 $6.28 2/28/2020389,800 shares $2.05 million -5.2%0.6%0.3 $5.27 2/14/2020411,000 shares $2.91 million +13.8%0.6%0.3 $7.08 1/31/2020361,300 shares $2.79 million -16.4%0.5%0.3 $7.73 1/15/2020432,200 shares $3.31 million +39.4%0.6%0.4 $7.66 12/31/2019310,000 shares $1.86 million -32.2%0.5%0.3 $6.00 APTO Short Interest - Frequently Asked Questions What is Aptose Biosciences' current short interest? Short interest is the volume of Aptose Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 68,100 shares of APTO short. 0.70% of Aptose Biosciences' shares are currently sold short. Learn More on Aptose Biosciences' current short interest. What is a good short interest ratio for Aptose Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APTO shares currently have a short interest ratio of 1.0. Learn More on Aptose Biosciences's short interest ratio. Which institutional investors are shorting Aptose Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aptose Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aptose Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.70% of Aptose Biosciences' floating shares are currently sold short. Is Aptose Biosciences' short interest increasing or decreasing? Aptose Biosciences saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 68,100 shares, a drop of 18.4% from the previous total of 83,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aptose Biosciences' float size? Aptose Biosciences currently has issued a total of 16,290,000 shares. Some of Aptose Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aptose Biosciences currently has a public float of 9,700,000 shares. How does Aptose Biosciences' short interest compare to its competitors? 0.70% of Aptose Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Aptose Biosciences: Instil Bio, Inc. (0.53%), Passage Bio, Inc. (3.92%), AVROBIO, Inc. (0.47%), Curis, Inc. (1.11%), Ikena Oncology, Inc. (5.87%), Turnstone Biologics Corp. (5.06%), Genenta Science S.p.A. (0.01%), Protara Therapeutics, Inc. (6.61%), Dyadic International, Inc. (0.88%), Cidara Therapeutics, Inc. (1.69%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Aptose Biosciences stock? Short selling APTO is an investing strategy that aims to generate trading profit from Aptose Biosciences as its price is falling. APTO shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aptose Biosciences? A short squeeze for Aptose Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APTO, which in turn drives the price of the stock up even further. How often is Aptose Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APTO, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Instil Bio Short Interest Data Passage Bio Short Interest Data AVROBIO Short Interest Data Entera Bio Short Interest Data Curis Short Interest Data Ikena Oncology Short Interest Data Turnstone Biologics Short Interest Data Genenta Science Short Interest Data Protara Therapeutics Short Interest Data Dyadic International Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APTO) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarElon Musk’s Final Masterpiece: “X-9840”Paradigm PressBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
